USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Common Stock And Earnings Per Share (Tables)

6 Months Ended

Jul. 01, 2017


	Quarter Ended		Six Months Ended
	July 2,	July 1,	July 2,	July 1,
	2016	2017	2016	2017

Net earnings available to common shareholders	$ 25,762	$ 23,259	$ 48,061	$ 44,617


Weighted average common shares outstanding - basic	23,955	24,574	24,080	24,537

Dilutive effect of in-the-money equity awards	962	444	970	460

Weighted average common shares outstanding - diluted	24,917	25,018	25,050	24,997


Earnings per common share from net earnings - basic	$ 1.08	$ 0.95	$ 2.00	$ 1.82

Earnings per common share from net earnings - diluted	$ 1.03	$ 0.93	$ 1.92	$ 1.78


Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that
their effect would be anti-dilutive:
	Quarter Ended		Six Months Ended
	July 2,	July 1,	July 2,	July 1,
	2016	2017	2016	2017
	2,210	2,059	2,200	2,119